Advanced Search
Contact | Corporate | Help

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Sponsors:
  • Dana-Farber Cancer Institute
  • Genentech
  • Beth Israel Deaconess Medical Center
  • Brigham and Women's Hospital
Phases:
  • Phase II
IndicationsAcronym:
  • Prostate Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Male
Names:
  • Drug: Androgen Deprivation Therapy
  • Drug: bicalutamide
  • Drug: bevacizumab
Enrollment:
100

Additional information about NCT00776594.


SourceSolution © 2008-2012